Moleculin Biotech (NASDAQ:MBRX) Corporate Presentation Available OnlineOn January 8, 2025, Moleculin Biotech, Inc. (the “Company”) made public its corporate presentation, which is now accessible on the Company’s official website. The presentation det
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Moleculin Biotech’s 8K filing here. About Moleculin Biotech (Get Free Report) Moleculin Biotech, Inc, a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and […]
More Stories
BigBear.ai (NYSE:BBAI) Trading Down 2.4% – What’s Next?
BigBear.ai Holdings, Inc. (NYSE:BBAI – Get Free Report)’s share price traded down 2.4% on Friday . The stock traded as...
Klondike Silver (CVE:KS) Stock Price Down 33.3% – What’s Next?
Klondike Silver Corp. (CVE:KS – Get Free Report)’s stock price fell 33.3% during trading on Friday . The company traded...
Microbot Medical (NASDAQ: MBOT) Announces $8.6 Million Registered Direct Offering
Microbot Medical Inc., a Delaware corporation, has recently disclosed an agreement involving Securities Purchase Agreements with investors for a registered...
La Rosa Holdings Corp. Completes Acquisition of Baxpi and Beaches Franchisees
La Rosa Holdings Corp. (NASDAQ: LRHC) recently announced the completion of its acquisition of Baxpi Holdings LLC and La Rosa...
NextCure Initiates Phase 1 Study for B7-H4 ADC Therapy to Treat Multiple Cancers_
On January 10, 2025, NextCure, Inc. (NASDAQ: NXTC) made a significant announcement through a press release, indicating the dosing of...
ImmuCell Announces Strong Preliminary Sales Results for Q4 and Full Year 2024
ImmuCell Corporation (NASDAQ: ICCC) recently disclosed its preliminary, unaudited sales figures for the fourth quarter and full year that ended...